The article highlights a notable increase in A.D.H.D. diagnoses in the U.S., particularly among boys, where about 23% of 17-year-olds are affected. A decade shows a nearly 60% rise in prescriptions for A.D.H.D. medications. Paul Tough shares insights on how the understanding and treatment of A.D.H.D. have evolved and points to ongoing debates among scientists regarding the definition and diagnosis. No biological test exists for A.D.H.D., complicating clear identification as symptoms often overlap with other conditions such as anxiety or autism, prompting a need for reevaluation of treatment strategies.
Attention was something I worried about in my own children and in myself, too. But I didn't know much about the science behind attention.
Researchers in the 1930s saw immediate benefits when they treated jumpy kids with amphetamines, leading to a consensus on diagnosing and treating A.D.H.D.
Collection
[
|
...
]